Sciascia Thomas Insider Trades

Insider Trading History

Track insider trading activity for Sciascia Thomas. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $1.14M 85,000 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$898k 85,000 shares
$10.56
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $1.24M 92,000 shares
Last Trade
May 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$391k 60,000 shares
$6.51
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
Mar 25, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$17.4k 2,631 shares
$6.61
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $2.98M 221,373 shares
Last Trade
Mar 25, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.4k 2,631 shares
$6.60
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $3.01M 224,004 shares
Last Trade
Mar 25, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$17.4k 2,631 shares
$6.61
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $430k 32,000 shares
Last Trade
Mar 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$194k 32,000 shares
$6.07
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $1.56M 116,000 shares
Last Trade
Feb 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$490k 116,000 shares
$4.22
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $3.19M 236,811 shares
Last Trade
Aug 19, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49k 16,496 shares
$2.97
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
Aug 19, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49k 16,496 shares
$2.97
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $2.96M 220,315 shares
Last Trade
Aug 19, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$48.8k 16,496 shares
$2.96
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $3.21M 238,975 shares
Last Trade
Aug 16, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$51.7k 18,660 shares
$2.77
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $2.96M 220,315 shares
Last Trade
Aug 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$51.5k 18,660 shares
$2.76
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $222k 16,496 shares
Last Trade
Aug 16, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$51.7k 18,660 shares
$2.77
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $473k 35,156 shares
Last Trade
Aug 15, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$35k 12,745 shares
$2.75
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $2.96M 220,315 shares
Last Trade
Aug 15, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$35.6k 12,745 shares
$2.79
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $3.13M 233,060 shares
Last Trade
Aug 15, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$35k 12,745 shares
$2.75
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $2.96M 220,315 shares
Last Trade
Aug 14, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$275 100 shares
$2.75
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $2.96M 220,415 shares
Last Trade
Aug 14, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$261 100 shares
$2.61
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $644k 47,901 shares
Last Trade
Aug 14, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$261 100 shares
$2.61
$13.45
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $2.88M 214,433 shares
Last Trade
May 29, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$136k 53,368 shares
$2.55
$13.45

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up